Director General, MSD Pharmaceuticals LLC; Managing Director, MSD Russia, Belarus and Kazakhstan
- 15 January
- IMMUNOPROPHYLAXIS: PROSPECTS OF DEVELOPMENT UP TO 2035 Building 5, Floor 5, Conference Hall
- 16 January
- BUDGET BALANCE OF THE FUTURE HEALTHCARE Building 5, Floor 5, Assembly Hall
Marwan Akar has been working as the Managing Director of MSD Pharmaceuticals since 2017. In this position, he is responsible for directing MSD (Merck Sharp & Dohme) operations in Russia.
Mr. Akar has been with the company for more than 20 years. Prior to his appointment to Russia, he was the Head of the Executive Office, Emerging Markets Region. In this position, Mr. Akar was responsible for developing and implementing the company's strategic projects in the countries of the Asia-Pacific Region (excluding China and Japan), Latin America (including Brazil), Eastern Europe, the Middle East and Africa.
Prior to this, Mr. Akar was the Managing Director of MSD in Egypt. His work in this department resulted in the increase in organizational efficiency and the growth of the company's business in key therapeutic areas.
Mr. Akar began his career in MSD as a production process engineer. As he progressed, Mr. Akar held various positions with increasing responsibilities, managed transfer technology projects for the production of vaccines and other drugs, and contributed to the increase of the production capacity of MSD and partner companies around the world.
In 2008, Mr. Akar was appointed as Head of Operations, MSD in EEMEA (the Eastern Europe, Middle East and Africa) & EUCAN (Europe and Canada). In this position, he supported strategic business development projects, and was responsible for the partner relationships with local manufacturers, including those in Russia.
Mr. Akar received a master’s degree in Chemical Engineering from the University of Maryland (USA). He also completed the MBA (Master of Business Administration) program at Imperial College London.